IVA
Latest News for IVA
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), Stereotaxis (STXS) and Merck & Comp......
Inventiva SA (($FR:IVA)) has held its Q4 earnings call. Read on for the main highlights of the call. Inventiva SA’s latest earnings call struck a c......
Barclays analyst Eliana Merle maintained a Buy rating on Inventiva today and set a price target of $18.00. According to TipRanks, Merle is a 3-star......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), MAIA Biotechnology, Inc. (MAIA) and......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), PolyPid (PYPD) and Soligenix (SNGX)......
Inventiva ( ($IVA) ) has shared an announcement. On March 30, 2026, Inventiva reported its 2025 results, highlighting revenues of €4.5 million, cas......
LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Inventiva today and set a price target of $14.00. Katkhuda covers the Healthcare s......
LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Inventiva today and set a price target of $14.00. Katkhuda covers the Healthcare s......
UBS analyst reiterated a Buy rating on Vivara Participacoes SA today and set a price target of BRL34.00. Vivara Participacoes SA has an analyst con......
News data is sourced from MarketXLS API and updated regularly.
Showing 9 of 9 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IVA | $5.66 | -1.4% | 524.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |